Nanotechnology-applied Curcumin for Different Diseases Therapy

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2014 Jul 5

PMID 24995293

Citations 76

Authors

Negar Ghalandarlaki

Ali Mohammad Alizadeh

Soheil Ashkani-Esfahani

Affiliations

Soon will be listed here.

Abstract

Curcumin is a lipophilic molecule with an active ingredient in the herbal remedy and dietary spice turmeric. It is used by different folks for treatment of many diseases. Recent studies have discussed poor bioavailability of curcumin because of poor absorption, rapid metabolism, and rapid systemic elimination. Nanotechnology is an emerging field that is potentially changing the way we can treat diseases through drug delivery with curcumin. The recent investigations established several approaches to improve the bioavailability, to increase the plasma concentration, and to enhance the cellular permeability processes of curcumin. Several types of nanoparticles have been found to be suitable for the encapsulation or loading of curcumin to improve its therapeutic effects in different diseases. Nanoparticles such as liposomes, polymeric nanoparticles, micelles, nanogels, niosomes, cyclodextrins, dendrimers, silvers, and solid lipids are emerging as one of the useful alternatives that have been shown to deliver therapeutic concentrations of curcumin. This review shows that curcumin's therapeutic effects may increase to some extent in the presence of nanotechnology. The presented board of evidence focuses on the valuable special effects of curcumin on different diseases and candidates it for future clinical studies in the realm of these diseases.

Citing Articles

Nephrotoxic effect of cypermethrin ameliorated by nanocurcumin through antioxidative mechanism.

Alshahrani S, Ashafaq M, Jali A, Almoshari Y, Alam M, Al Shahi H Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39878820 DOI: 10.1007/s00210-025-03825-5.

Epoxy-a-lapachone in nanosystem: a prototype drug for leishmaniasis assessed in the binomial BALB/c - Leishmania (Leishmania) amazonensis.

Peixoto J, Goncalves-Oliveira L, Dias-Lopes G, Souza-Silva F, Alves C Mem Inst Oswaldo Cruz. 2024; 119:e240115.

PMID: 39476028 PMC: 11520661. DOI: 10.1590/0074-02760240115.

Nanocurcumin in cancer treatment: a comprehensive systematic review.

Boroughani M, Moaveni A, Hatami P, Mansoob Abasi N, Seyedoshohadaei S, Pooladi A Discov Oncol. 2024; 15(1):515.

PMID: 39349709 PMC: 11442806. DOI: 10.1007/s12672-024-01272-x.

Nanocurcumin-Based Sugar-Free Formulation: Development and Impact on Diabetes and Oxidative Stress Reduction.

Ferradj S, Yahoum M, Rebiha M, Nabi I, Toumi S, Lefnaoui S Nanomaterials (Basel). 2024; 14(13).

PMID: 38998710 PMC: 11243456. DOI: 10.3390/nano14131105.

Innovative Delivery Systems for Curcumin: Exploring Nanosized and Conventional Formulations.

Yakubu J, Pandey A Pharmaceutics. 2024; 16(5).

PMID: 38794299 PMC: 11125045. DOI: 10.3390/pharmaceutics16050637.

References

Anand P, Kunnumakkara A, Newman R, Aggarwal B . Bioavailability of curcumin: problems and promises. Mol Pharm. 2007; 4(6):807-18. DOI: 10.1021/mp700113r. View

Ohtsu H, Xiao Z, Ishida J, Nagai M, Wang H, Itokawa H . Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents. J Med Chem. 2002; 45(23):5037-42. DOI: 10.1021/jm020200g. View

Chen Y, Wu Q, Zhang Z, Yuan L, Liu X, Zhou L . Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules. 2012; 17(5):5972-87. PMC: 6268695. DOI: 10.3390/molecules17055972. View

Mondal S, Ghosh S . Role of curcumin on the determination of the critical micellar concentration by absorbance, fluorescence and fluorescence anisotropy techniques. J Photochem Photobiol B. 2012; 115:9-15. DOI: 10.1016/j.jphotobiol.2012.06.004. View

Yadav V, Prasad S, Kannappan R, Ravindran J, Chaturvedi M, Vaahtera L . Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. Biochem Pharmacol. 2010; 80(7):1021-32. PMC: 2923254. DOI: 10.1016/j.bcp.2010.06.022. View

Pandelidou M, Dimas K, Georgopoulos A, Hatziantoniou S, Demetzos C . Preparation and characterization of lyophilised egg PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines. J Nanosci Nanotechnol. 2011; 11(2):1259-66. DOI: 10.1166/jnn.2011.3093. View

Kakkar V, Muppu S, Chopra K, Kaur I . Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats. Eur J Pharm Biopharm. 2013; 85(3 Pt A):339-45. DOI: 10.1016/j.ejpb.2013.02.005. View

Alizadeh A, Khaniki M, Azizian S, Mohaghgheghi M, Sadeghizadeh M, Najafi F . Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier--curcumin. Eur J Pharmacol. 2012; 689(1-3):226-32. DOI: 10.1016/j.ejphar.2012.06.016. View

Mandal S, Banerjee C, Ghosh S, Kuchlyan J, Sarkar N . Modulation of the photophysical properties of curcumin in nonionic surfactant (Tween-20) forming micelles and niosomes: a comparative study of different microenvironments. J Phys Chem B. 2013; 117(23):6957-68. DOI: 10.1021/jp403724g. View

10.

Manju S, Sreenivasan K . Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells. J Colloid Interface Sci. 2011; 368(1):144-51. DOI: 10.1016/j.jcis.2011.11.024. View

11.

Wu W, Shen J, Banerjee P, Zhou S . Water-dispersible multifunctional hybrid nanogels for combined curcumin and photothermal therapy. Biomaterials. 2010; 32(2):598-609. DOI: 10.1016/j.biomaterials.2010.08.112. View

12.

Jones M, Leroux J . Polymeric micelles - a new generation of colloidal drug carriers. Eur J Pharm Biopharm. 1999; 48(2):101-11. DOI: 10.1016/s0939-6411(99)00039-9. View

13.

Adhikary R, Carlson P, Kee T, Petrich J . Excited-state intramolecular hydrogen atom transfer of curcumin in surfactant micelles. J Phys Chem B. 2010; 114(8):2997-3004. DOI: 10.1021/jp9101527. View

14.

Zhang J, Tang Q, Xu X, Li N . Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery. Int J Pharm. 2013; 448(1):168-74. DOI: 10.1016/j.ijpharm.2013.03.021. View

15.

Rejinold N, Sreerekha P, Chennazhi K, Nair S, Jayakumar R . Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery. Int J Biol Macromol. 2011; 49(2):161-72. DOI: 10.1016/j.ijbiomac.2011.04.008. View

16.

Rogers N, Stephenson M, Kitching A, Horowitz J, Coates P . Amelioration of renal ischaemia-reperfusion injury by liposomal delivery of curcumin to renal tubular epithelial and antigen-presenting cells. Br J Pharmacol. 2011; 166(1):194-209. PMC: 3415648. DOI: 10.1111/j.1476-5381.2011.01590.x. View

17.

Agarwal N, Jain S, Nagpal D, Agarwal N, Mediratta P, Sharma K . Liposomal formulation of curcumin attenuates seizures in different experimental models of epilepsy in mice. Fundam Clin Pharmacol. 2011; 27(2):169-72. DOI: 10.1111/j.1472-8206.2011.01002.x. View

18.

Basnet P, Hussain H, Tho I, Skalko-Basnet N . Liposomal delivery system enhances anti-inflammatory properties of curcumin. J Pharm Sci. 2011; 101(2):598-609. DOI: 10.1002/jps.22785. View

19.

Gou M, Men K, Shi H, Xiang M, Zhang J, Song J . Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale. 2011; 3(4):1558-67. DOI: 10.1039/c0nr00758g. View

20.

Yu H, Li J, Shi K, Huang Q . Structure of modified ε-polylysine micelles and their application in improving cellular antioxidant activity of curcuminoids. Food Funct. 2011; 2(7):373-80. PMC: 3226345. DOI: 10.1039/c1fo10053j. View